checkAd

    DGAP-News  543  0 Kommentare Marketing agreement between Artel and STRATEC


    DGAP-News: STRATEC Biomedical AG / Key word(s): Agreement/Alliance
    Marketing agreement between Artel and STRATEC

    12.01.2015 / 09:29

    ---------------------------------------------------------------------

    Marketing agreement between Artel and STRATEC

    Birkenfeld, January 12, 2015

    STRATEC Biomedical AG, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard,
    TecDAX) and Artel, Westbrook, Maine, USA, the worldwide leader in
    laboratory liquid handling quality assurance, have announced an exclusive
    marketing agreement for STRATEC's patented "Tholos" liquid handling quality
    assurance instrumentation solution.

    Under the agreement, effective as of January 1, 2015, Artel will
    exclusively market the "Tholos" technology developed by STRATEC under
    Artel's brand name in its core markets.

    STRATEC's "Tholos" measures the volume of liquids in reaction wells using
    an innovative pressure-based technology that accurately and repeatedly
    assesses volume regardless of the size of the reaction well, its shape or
    coloring. This makes it possible to record critical process parameters for
    sample handling operations in laboratory applications in the pharmaceutical
    industry, life science research, production and assay development. The
    system can therefore be used as an in-process control for nearly all types
    of liquid handling applications.

    "Our customers will benefit from this powerful technology, which further
    enhances their ability to ensure high-quality results", says Kirby Pilcher,
    president of Artel. "The strategic partnership with STRATEC, a leader in
    providing automated systems used in laboratories worldwide, has resulted in
    a perfect addition to Artel's portfolio of liquid handling quality
    assurance products and services".

    "The system is an innovative volume control solution that closes a gap in
    in-process control for high throughput automation processes", added Marcus
    Wolfinger, Chairman, Board of Management of STRATEC. "We are very proud to
    have gained Artel, the global market leader in liquid handling quality
    assurance, as a partner".

    About Artel
    Laboratories worldwide depend upon Artel technology and expertise to
    standardize and optimize their liquid handling instruments and processes,
    and to give them total confidence in their results. Since 1982, Artel has
    been solving liquid handling quality, productivity and compliance
    challenges in laboratories in pharmaceutical and biotechnology research,
    regulatory bodies, academia, clinical diagnostics, forensics, public
    health, agbio, food quality and safety and environmental testing.

    Artel provides quality assurance systems and a broad and fully customizable
    Seite 1 von 2


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News Marketing agreement between Artel and STRATEC DGAP-News: STRATEC Biomedical AG / Key word(s): Agreement/Alliance Marketing agreement between Artel and STRATEC 12.01.2015 / 09:29 --------------------------------------------------------------------- Marketing agreement between Artel and STRATEC …

    Schreibe Deinen Kommentar

    Disclaimer